Skip to main content
Log in

Social Anxiety and Quality of Life in Vitiligo and Acne Patients with Facial Involvement: A Cross-Sectional Controlled Study

  • Original Research Article
  • Published:
American Journal of Clinical Dermatology Aims and scope Submit manuscript

Abstract

Background

Vitiligo and acne vulgaris, commonly affecting the face, have significant psychological effects and impair the quality of life of the affected individuals. Because of their negative effect on physical appearance, these conditions may act as a potential barrier to social relationships and cause social anxiety.

Objective

The objective of the study was to investigate the social anxiety, quality of life, anxiety, and depression levels of acne and vitiligo patients with facial involvement and compare these levels with healthy controls.

Methods

Thirty-seven vitiligo and 37 acne patients, aged older than 18 years, with facial involvement and 74 age- and sex-matched healthy control subjects were included in the study. The patients and healthy controls were asked to complete the Liebowitz Social Anxiety Scale, the Hospital Anxiety and Depression Scale, and the Dermatology Life Quality Index. Disease severity was evaluated both objectively by the physician and subjectively by the patients using a visual analog scale.

Results

Social anxiety, depression, and anxiety levels of vitiligo and acne patients were significantly higher than healthy controls (p < 0.05). Quality of life was impaired in both patient groups (Dermatology Life Quality Index scores for vitiligo: 5.6 ± 5.1; acne: 6.4 ± 6.2). There was no correlation between psychiatric scale scores and disease severity. Quality of life was negatively correlated with social anxiety and depression levels in both patient groups in our study.

Conclusion

Vitiligo and acne patients had higher levels of social anxiety, anxiety, and depression compared with healthy control subjects. Considering that increased psychosocial morbidity was regardless of age, sex, and disease severity and was correlated with quality of life impairment, evaluation of the psychosocial morbidity, in particular social anxiety, may be valuable in all vitiligo and acne patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Timms RM. Moderate acne as a potential barrier to social relationships: myth of reality? Psyhcol Health Med. 2013;18:310–20.

    Article  Google Scholar 

  2. Ongenae K, Beelaert L, van Geel N, Naeyaert JM. Psychosocial effects of vitiligo. J Eur Acad Dermatol Venereol. 2006;20:1–8.

    Article  CAS  PubMed  Google Scholar 

  3. Kent G, al-Abadie M. Factors affecting responses on Dermatology Life Quality Index items among vitiligo sufferers. Clin Exp Dermatol. 1996;21:330–3.

    Article  CAS  PubMed  Google Scholar 

  4. Parsad D, Dogra S, Kanwar AJ. Quality of life in patients with vitiligo. Health Qual Life Outcomes. 2003;1:58–60.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Homan MWL, Spuls PI, de Korte J, Bos JD, Sprangers MA, van der Veen JP. The burden of vitiligo: patient characteristics associated with quality of life. J Am Acad Dermatol. 2009;61:411–20.

    Article  Google Scholar 

  6. Ruscio AM, Brown TA, Chiu WT, Sareen J, Stein MB, Kessler RC. Social fears and social phobia in the USA: results from the National Comorbidity Survey Replication. Psychol Med. 2008;38:15–28.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Koyuncu A, Ertekin E, Deveci E, et al. Age of onset in social anxiety disorder: relation to clinical variables and major depression comorbidity. Ann Clin Psychiatry. 2015;27:84–9.

    PubMed  Google Scholar 

  8. Stein MB, Stein DJ. Social anxiety disorder. Lancet. 2008;371:1115–25.

    Article  PubMed  Google Scholar 

  9. Brook CA, Schmidt LA. Social anxiety disorder: a review of environmental risk factors. Neuropsychiatr Dis Treat. 2008;4:123–43.

    PubMed  PubMed Central  Google Scholar 

  10. Ongenae K, Van Geel N, De Schepper S, Naeyaert JM. Effect of vitiligo on self-reported health-related quality of life. Br J Dermatol. 2005;152:1165–72.

    Article  CAS  PubMed  Google Scholar 

  11. Mallon E, Newton JN, Klassen A, Stewart-Brown SL, Ryan TJ, Finlay AY. The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Br J Dermatol. 1999;140:672–6.

    Article  CAS  PubMed  Google Scholar 

  12. Ahmed A, Leon A, Butler DC, Reichenberg J. Quality-of-life effects of common dermatological diseases. Semin Cutan Med Surg. 2013;32:101–9.

    Article  PubMed  Google Scholar 

  13. Yarpuz AY, Saadet ED, Sanli HE, Ozguven HD. Social anxiety level in acne vulgaris patients and its relationship to clinical variables. Turk Psikiyatri Derg. 2008;19:29–37.

    Google Scholar 

  14. Bez Y, Yesilova Y, Kaya MC, Sir A. High social phobia frequency and related disability in patients with acne vulgaris. Eur J Dermatol. 2011;21:756–60.

    PubMed  Google Scholar 

  15. Loney T, Standage M, Lewis S. Not just ‘skin deep’: psychosocial effects of dermatological-related social anxiety in a sample of acne patients. J Heatlh Psychol. 2008;13:47–54.

    Article  Google Scholar 

  16. Balaban OD, Atagun MI, Ozguven HD, Ozsan HH. Psychiatric morbidity in patients with vitiligo. Dusunen Adam. 2011;24:306–13.

    Article  Google Scholar 

  17. Krüger C, Schallreuter KU. Stigmatisation, avoidance behaviour and difficulties in coping are common among adult patients with vitiligo. Acta Derm Venereol. 2015;95:553–8.

    Article  PubMed  Google Scholar 

  18. Hughes JE, Barraclough BM, Hamblin LG, White JE. Psychiatric symptoms in dermatology patients. Br J Psychiatry. 1983;143:51–4.

    Article  CAS  PubMed  Google Scholar 

  19. Picardi A, Abeni D, Renzi C, Braga M, Puddu P, Pasquini P. Increased psychiatric morbidity in female outpatients with skin lesions on visible parts of the body. Acta Derm Venereol. 2001;81:410–4.

    Article  CAS  PubMed  Google Scholar 

  20. Nast A, Dreno B, Bettoli V, et al. European evidence-based (S3) guidelines for the treatment of acne. J Eur Acad Dermatol Venereol. 2012;26(S1):1–29.

    Article  PubMed  Google Scholar 

  21. Liebowitz MR. Social phobia. Mod Probl Pharmacopsychiatry. 1987;22:141–73.

    Article  CAS  PubMed  Google Scholar 

  22. Soykan C, Ozguven HD, Gencoz T. Liebowitz Social Anxiety Scale: the Turkish version. Psychol Rep. 2003;93:1059–69.

    Article  PubMed  Google Scholar 

  23. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–70.

    Article  CAS  PubMed  Google Scholar 

  24. Aydemir O, Guvenir T, Kuey L, Kultur S. Hastane anksiyete ve depresyon olçegi Turkce formunun gecerlilik ve guvenilirligi. Turk Psikiyatri Derg. 1997;8:280–7.

    Google Scholar 

  25. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210–6.

    Article  CAS  PubMed  Google Scholar 

  26. Oztürkcan S, Ermertcan AT, Eser E, Sahin MT. Cross validation of the Turkish version of Dermatology Life Quality Index. Int J Dermatol. 2006;45:1300–7.

    Article  PubMed  Google Scholar 

  27. Shah R, Hunt J, Webb TL, Thompson AR. Starting to develop self-help for social anxiety associated with vitiligo: using clinical significance to measure the potential effectiveness of enhanced psychological self-help. Br J Dermatol. 2014;171:332–7.

    Article  CAS  PubMed  Google Scholar 

  28. Khattri S, Bist JS, Arun A, Mehta AK. Clinical correlates of vitiligo with depression and anxiety: a comparative study in patients and their caregivers. Int J Adv Res. 2015;3:200–5.

    Google Scholar 

  29. Ozturk A, Deveci E, Bagcioglu E, Atalay F, Serdar Z. Anxiety, depression, social phobia, and quality of life in Turkish patients with acne and their relationships with the severity of acne. Turk J Med Sci. 2013;43:660–6.

    Article  Google Scholar 

  30. Clark DM, Wells A. A cognitive model of social phobia. In: Heimberg RG, Liebowitz MR, Hope DA, Schenier FR, editors. Social phobia: diagnosis, assessment, and treatment. New York: Guilford Press; 1995. p. 69–74.

    Google Scholar 

  31. Yazici K, Baz K, Yazici AE, et al. Disease-specific quality of life is associated with anxiety and depression in patients with acne. J Eur Acad Dermatol Venereol. 2004;18:435–9.

    Article  CAS  PubMed  Google Scholar 

  32. Kostopoulou P, Jouary T, Quintard B, et al. Objective vs. subjective factors in the psychological impact of vitiligo: the experience from a French referral centre. Br J Dermatol. 2009;161:128–33.

    Article  CAS  PubMed  Google Scholar 

  33. Parsad D, Pandhi R, Dogra S, Kanwar AJ, Kumar B. Dermatology Life Quality Index score in vitiligo and its impact on the treatment outcome. Br J Dermatol. 2003;148:373–4.

    Article  CAS  PubMed  Google Scholar 

  34. Lasek RJ, Chren MM. Acne vulgaris and the quality of life of adult dermatology patients. Arch Dermatol. 1998;134:454–8.

    Article  CAS  PubMed  Google Scholar 

  35. Wittkowski A, Richards HL, Griffiths CE, Main CJ. The impact of psychological and clinical factors on quality of life in individuals with atopic dermatitis. J Psychosom Res. 2004;57:195–200.

    Article  PubMed  Google Scholar 

  36. Sampogna F, Picardi A, Chren MM, et al. Association between poorer quality of life and psychiatric morbidity in patients with different dermatological conditions. Psychosom Med. 2004;66:620–4.

    Article  PubMed  Google Scholar 

  37. Sampogna F, Raskovic D, Guerra L, et al. Identification of categories at risk for high quality of life impairment in patients with vitiligo. Br J Dermatol. 2008;159:351–9.

    Article  CAS  PubMed  Google Scholar 

  38. Ramakrishna P, Rajni T. Psychiatric morbidity and quality of life in vitiligo patients. Indian J Psychol Med. 2014;36:302–3.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Demircay Z, Seckin D, Senol A, Demir F. Patient’s perspective: an important issue not to be overlooked in assessing acne severity. Eur J Dermatol. 2008;18:181–4.

    PubMed  Google Scholar 

  40. Magin PJ, Pond CD, Smith WT, Watson AB, Goode SM. Correlation and agreement of self-assessed and objective skin disease severity in a cross-sectional study of patients with acne, psoriasis, and atopic eczema. Int J Dermatol. 2011;50:1486–90.

    Article  PubMed  Google Scholar 

  41. Gupta MA, Gupta AK. Psychiatric and psychological co-morbidity in patients with dermatologic disorders: epidemiology and management. Am J Clin Dermatol. 2003;4:833–42.

    Article  PubMed  Google Scholar 

  42. Gupta MA, Gupta AK. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol. 1998;139:846–50.

    Article  CAS  PubMed  Google Scholar 

  43. Woodruff PW, Higgins EM, du Vivier AW, Wessely S. Psychiatric illness in patients referred to a dermatology-psychiatry clinic. Gen Hosp Psychiatry. 1997;19:29–35.

    Article  CAS  PubMed  Google Scholar 

  44. Kent G, Al’Abadie M. Psyshologic effects of vitiligo: a critical incident analysis. J Am Acad Dermatol. 1996;35:895–8.

    Article  CAS  PubMed  Google Scholar 

  45. Niemeier V, Kupfer J, Gieler U. Acne vulgaris-psychosomatic aspects. J Dtsch Dermatol Ges. 2006;4:1027–36.

    Article  PubMed  Google Scholar 

  46. Moretti S, Arunachalam M, Colucci R, et al. Autoimmune markers in vitiligo patients appear correlated with obsession and phobia. J Eur Acad Dermatol Venereol. 2012;26:861–7.

    Article  CAS  PubMed  Google Scholar 

  47. Mattoo SK, Handa S, Kaur I, Gupta N, Malhotra R. Psyhiatric morbidity in vitiligo: prevalence and correlates in India. J Eur Acad Dermatol Venereol. 2002;16:573–8.

    Article  CAS  PubMed  Google Scholar 

  48. Stein MB, Kean YM. Disability and quality of life in social phobia: epidemiologic findings. Am J Psychiatry. 2000;157:1606–13.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andac Salman.

Ethics declarations

Conflict of interest

Andac Salman, Emel Kurt, Volkan Topcuoglu, and Zeynep Demircay have no conflict of interest.

Funding

No funding was received for the preparation of this review.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Salman, A., Kurt, E., Topcuoglu, V. et al. Social Anxiety and Quality of Life in Vitiligo and Acne Patients with Facial Involvement: A Cross-Sectional Controlled Study. Am J Clin Dermatol 17, 305–311 (2016). https://doi.org/10.1007/s40257-016-0172-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40257-016-0172-x

Keywords

Navigation